MedTrace Logo

Melanoma Accuracy Study; Phase 2

NCT03464604 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 121

Last updated 2022-11-23

No results posted yet for this study

Summary

The purpose of this study is to evaluate the process, accuracy and patient outcomes of pre-screening dermatology referrals in a clinical setting by a qualified nurse. The long-range goal of the proposed program is to improve referral wait times for patients to see a dermatologist for lesions suspicious for melanoma in comparison to normal standards of care in NS. If effective, this screening program would decrease wait times for those patients with lesions suspicious for melanoma providing earlier diagnosis and expedited treatment, and potentially reducing mortality rates.

Conditions

Interventions

DIAGNOSTIC_TEST

active

Pre-screening for melanoma by qualified nurse

Sponsors & Collaborators

  • Nova Scotia Health Authority

    lead OTHER

Principal Investigators

  • Richard G Lngley, PhD · Nova Scotia Health Authority

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-02-28
Primary Completion
2018-10-10
Completion
2018-10-10

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03464604 on ClinicalTrials.gov